Tumor marker response to SARS‐CoV‐2 infection among patients with cancer.Published in:Cancer Medicine, 2022, v. 11, n. 14, p. 2865, doi. 10.1002/cam4.4646By:Gunn, Alexander H.;Tashie, Carolyn;Wolf, Steven;Troy, Jesse D.;Zafar, YousufPublication type:Article